Pacific Biosciences of California, Inc. Share Price
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.360 USD | +10.80% |
|
+10.80% | +26.20% |
| Capitalization | 713M 611M 569M 530M 989M 64.32B 1.07B 6.54B 2.57B 30.77B 2.67B 2.62B 113B | P/E ratio 2025 * |
-1.28x | P/E ratio 2026 * | -4.27x |
|---|---|---|---|---|---|
| Enterprise value | 1.08B 926M 862M 802M 1.5B 97.39B 1.61B 9.91B 3.9B 46.59B 4.05B 3.96B 171B | EV / Sales 2025 * |
6.85x | EV / Sales 2026 * | 6.63x |
| Free-Float |
90.66% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Pacific Biosciences of California, Inc.
More recommendations
More press releases
More news
| 1 day | +10.80% | ||
| 1 week | +10.80% | ||
| Current month | +26.20% | ||
| 1 month | +11.32% | ||
| 3 months | +48.43% | ||
| 6 months | +61.64% | ||
| Current year | +26.20% |
| 1 week | 1.84 | 2.37 | |
| 1 month | 1.67 | 2.37 | |
| Current year | 1.79 | 2.37 | |
| 1 year | 0.85 | 2.72 | |
| 3 years | 0.85 | 14.55 | |
| 5 years | 0.85 | 53.69 | |
| 10 years | 0.85 | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christian Henry
CEO | Chief Executive Officer | 58 | 13/09/2020 |
Stephen Turner
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/12/2003 |
James R. Gibson
DFI | Director of Finance/CFO | 57 | 30/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 31/12/2003 |
| Director/Board Member | 72 | 31/12/2008 | |
Marshall Mohr
BRD | Director/Board Member | 69 | 17/01/2012 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +10.80% | +10.80% | +27.57% | -78.47% | 643M | ||
| +2.43% | +0.76% | +11.64% | +6.51% | 228B | ||
| -2.68% | -7.68% | +1.46% | +111.19% | 199B | ||
| +1.01% | +1.01% | +0.14% | -13.04% | 166B | ||
| -0.42% | -4.98% | -2.00% | +101.46% | 140B | ||
| +0.66% | +2.06% | -7.27% | -5.56% | 60.69B | ||
| -0.88% | -2.04% | +16.98% | +6.12% | 48.65B | ||
| -0.27% | -1.28% | +1.74% | -7.01% | 41.48B | ||
| +0.63% | -0.54% | +1.39% | +30.35% | 38.61B | ||
| +1.90% | +4.55% | +13.41% | +18.99% | 37.1B | ||
| Average | +1.32% | +0.22% | +6.51% | +17.05% | 96.04B | |
| Weighted average by Cap. | +0.23% | -1.86% | +3.87% | +38.65% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 157M 135M 126M 117M 218M 14.21B 235M 1.45B 569M 6.8B 590M 578M 24.91B | 178M 153M 142M 133M 247M 16.09B 267M 1.64B 644M 7.7B 669M 655M 28.21B |
| Net income | -551M -473M -441M -410M -765M -49.78B -825M -5.06B -1.99B -23.81B -2.07B -2.03B -87.25B | -170M -146M -136M -126M -236M -15.36B -254M -1.56B -615M -7.35B -638M -625M -26.92B |
| Net Debt | 366M 314M 293M 272M 508M 33.07B 548M 3.36B 1.32B 15.82B 1.37B 1.35B 57.96B | 469M 402M 375M 349M 651M 42.33B 701M 4.31B 1.69B 20.25B 1.76B 1.72B 74.19B |
More financial data
* Estimated data
Employees
575
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 2.360 $ | +10.80% | 11,628,897 |
| 13/01/26 | 2.130 $ | +5.97% | 9,399,128 |
| 12/01/26 | 2.010 $ | +3.61% | 10,723,423 |
| 09/01/26 | 1.940 $ | -4.90% | 11,465,618 |
| 08/01/26 | 2.040 $ | -4.23% | 6,793,555 |
Delayed Quote Nasdaq, January 14, 2026 at 09:00 pm
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
2.360USD
Average target price
2.417USD
Spread / Average Target
+2.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















